🔗 Share this article

Chancellor Reeves has stated she is planning "targeted measures to tackle cost of living challenges" in the forthcoming Budget.

Speaking to the BBC, she emphasized that curbing inflation is a collective responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the Group of Seven developed nations this year and next.

Potential Utility Bill Measures

Sources suggest the administration could intervene to lower utility costs, for example by slashing the current 5% level of value-added tax applied on energy supplies.

An additional option is to lower some of the policy costs currently included in bills.

Fiscal Limitations and Analyst Expectations

The government will receive the latest assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much space there is for these actions.

The view from most analysts is that Reeves will have to announce tax increases or spending cuts in order to adhere to her voluntary borrowing rules.

Previously on Thursday, estimates suggested there was a £22bn gap for the chancellor to address, which is at the lower end of forecasts.

"There's a collective job between the Bank of England and the administration to further reduce some of the drivers of price increases," Reeves stated to reporters in Washington, at the annual meetings of the IMF and World Bank.

Revenue Commitments and International Issues

While much of the focus has been on likely tax increases, the chancellor said the most recent information from the OBR had not changed her pledge to campaign commitments not to raise tax levels on earnings tax, sales tax or social security contributions.

She attributed an "unpredictable world" with growing international and commercial issues for the fiscal tax moves, likely to be focused on those "most able to pay."

International Trade Disputes

Commenting on apprehensions about the United Kingdom's economic relations with China she said: "Our national security always are paramount."

Recent declaration by China to tighten export controls on rare earths and other resources that are key for advanced tech production led American leader Donald Trump to suggest an extra 100% tariff on imports from China, increasing the risk of an all-out commercial conflict between the two global powers.

The American finance chief described the Chinese action "economic coercion" and "a international production power grab."

Inquired about considering the US offer to join its battle with China, the Chancellor said she was "deeply worried" by Chinese actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "harmful for the world economy and generates further obstacles."

"In my view there are areas where we should confront Chinese policies, but there are also important opportunities to sell into Chinese markets, including financial services and other areas of the economic system. We've got to get that equilibrium correct."

The chancellor also stated she was working with G7 counterparts "on our own essential resources strategy, so that we are reduced dependence."

Health Service Medicine Costs and Investment

The Chancellor also admitted that the price the National Health Service spends on medicines could rise as a consequence of ongoing negotiations with the US government and its pharmaceutical firms, in exchange for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either delaying or abandoning operations in the UK, with some attributing the insufficient payments they are getting.

Last month, the Science Minister said the price the health service pays for medicines would must increase to halt firms and pharmaceutical investment leaving the UK.

Reeves informed media: "We have seen because of the payment system, that clinical trials, innovative medicines have not been provided in the UK in the way that they are in other European countries."

"The objective is to make sure that individuals receiving treatment from the National Health Service are can access the best essential treatments in the globe. And so we are reviewing this situation, and... looking to obtain increased investment into the UK."